Trevena's IPO

Trevena raised a round of funding on January 31, 2014. Investors include Public.

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR d…

Articles about Trevena's IPO: